Graf Akcie AMRX (Amneal Pharmaceuticals Inc). Diskuze k akciím AMRX. Aktuální informace AMRX.

Základní informace o společnosti Amneal Pharmaceuticals Inc (Akcie AMRX)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 875.22M
Hodnota podniku (EV) 3.33B
Tržby 2.058B
EBITDA 413.853M
Zisk 9.226M
Růst v tržbách Q/Q 15.15 %
Růst v tržbách Y/Y 18.33 %
P/E (Cena vůči ziskům) 80.57
Forward P/E N/A
EV/Sales 1.62
EV/EBITDA 8.05
EV/EBIT 22.04
PEG N/A
Price/Sales 0.43
P/FCF 4.87
Price/Book 2.89
Účetní hodnota na akcii 1.95
Hotovost na akcii 2.24
FCF vůči ceně 20.54 %
Počet zaměstnanců 6,000
Tržba na zaměstnance 342.918k
Profit margin 4.57 %
Operating margin 6.59 %
Gross margin 31.54 %
EBIT margin 7.35 %
EBITDA margin 20.11 %
EPS - Zisk na akcii 0.07
EPS - Kvartální růst 92.31 %
EPS - Očekávaný růst příští rok 25.00 %
Return on assets 0.23 %
Return on equity 2.90 %
ROIC 3.53 %
ROCE 4.51 %
Dluhy/Equity 12.07
Čistý dluh/EBITDA 25.05
Current ratio 2.32
Quick Ratio 1.55
Volatilita 3.99
Beta 1.20
RSI 57.25
Cílová cena analytiků 4
Známka akcie (dle analytiků) 3.00
Insider ownership 10.30 %
Institutional ownership 60.57 %
Počet akcií 149.278M
Procento shortovaných akcií 4.58 %
Short ratio 5.06 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2018
Země United States

Finanční výsledky akcie AMRX

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$1,626.373$1,662.991$1,033.654$1,018.225$860.469$596.049
Cost Of Goods Sold$1,273.376$946.588$507.476$420.77$508.065$283.396
Gross Profit$352.997$716.403$526.178$597.455$352.404$312.653
Research And Development Expenses$188.049$194.19$171.42$179.019$70.622$78.642
SG&A Expenses$289.598$227.846$109.046$118.757$201.287$139.39
Other Operating Income Or Expenses$-26.68$3.45$8.794$-14.728$-4.567$-5.805
Operating Expenses$1,875.055$1,682.664$788.551$733.344$790.901$507.233
Operating Income$-248.682$-19.673$245.103$284.881$69.568$88.816
Total Non-Operating Income/Expense$28.44$-183.049$-73.78$-70.06$-10.2$1.743
Pre-Tax Income$-220.242$-202.722$171.323$214.821$59.368$90.559
Income Taxes$383.331$-1.419$1.998$5.395$20.371$33.206
Income After Taxes$-603.573$-201.303$169.325$209.426$38.997$57.353
Other Income------
Income From Continuous Operations$-603.573$-201.303$169.325$209.426$38.997$57.353
Income From Discontinued Operations------
Net Income$-361.917$-20.92--$38.997$57.353
EBITDA$1.424$134.012$295.624$320.952$138.205$122.842
EBIT$-248.682$-19.673$245.103$284.881$69.568$88.816
Basic Shares Outstanding132127--7068
Shares Outstanding132127--7271
Basic EPS$-2.74$-0.16--$0.56$0.84
EPS - Earnings Per Share$-2.74$-0.16--$0.54$0.81
# 2020 2019 2018 2017 2016 2015
Current Ratio2.19882.32312.60011.96422.51584.2573
Long-term Debt / Capital0.88510.74861.36830.56590.2855-
Debt/Equity Ratio7.76263.0026-3.95321.33220.3997-
Gross Margin21.704643.079250.904758.676140.954952.4543
Operating Margin-15.2906-1.18323.712327.97828.084914.9008
EBIT Margin-15.2906-1.18323.712327.97828.084914.9008
EBITDA Margin0.08768.058528.599931.520716.061620.6094
Pre-Tax Profit Margin-13.5419-12.190216.574521.09766.899515.1932
Net Profit Margin-22.253-1.258--4.53219.6222
Asset Turnover0.44370.38210.77030.55850.44760.5523
Inventory Turnover Ratio3.34162.07031.78662.40124.04573.5174
Receiveable Turnover2.68313.44792.81213.9032.65214.0689
Days Sales In Receivables136.0373105.8626129.797493.5172137.62889.7055
ROE - Return On Equity-174.0467-22.4578-45.083433.56333.67066.4596
Return On Tangible Equity41.469316.99-37.9121-102.7515.58496.8802
ROA - Return On Assets-16.4646-4.624712.618411.48792.02855.3144
ROI - Return On Investment-20.0038-5.64516.605714.56862.62256.4596
Book Value Per Share1.15913.0015-8.465814.617212.4655
Operating Cash Flow Per Share-1.95351.9664--1.28360.8183-1.7187
Free Cash Flow Per Share-1.85681.5126--0.93370.8925-1.6652